In this issue:
Comparison of new pharmacologic agents with triptans for migraine
Migraine prevalence, characteristics, triggers, and coping strategies among medical students in Saudi Arabia
CGRP MAbs vs standard prophylactic drugs in migraine
Differences in GMV in EM patients with and without prior diagnosis or clinical care
Clinical symptoms of androgen deficiency in men with migraine or cluster headache
Risk for ischaemic stroke and CHD associated with migraine and migraine medication
Anti-CGRP MAbs in CM with MO
Psychological predictors of negative treatment outcome with erenumab in CM
Long-term effectiveness, safety, and tolerability of erenumab in the prevention of HFEM and CM
Improvements in quality of life and work productivity with fremanezumab for EM and CM
Please login below to download this issue (PDF)